Trading Halt
Released
Released
Announcement PDF
Market Announcement
14 October 2026
14 October 2026 Market Announcement 1/1
ASX Limited ASX Customer Service Centre 131 279 | asx.com.au
Mayne Pharma Group Limited (ASX: MYX) – Trading Halt
Trading in the securities of Mayne Pharma Group Limited (‘MYX’) will be halted at the request of MYX, pending
the release of an announcement by MYX.
Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of:
• the commencement of normal trading on Friday, 16 October 2026; or
• the release of the announcement to the market.
MYX’s request for a trading halt is attached below for the information of the market.
Issued by
ASX Supervision
Wednesday, 14 October 2026
Manager, Company Announcements
ASX Limited
Level 27
39 Martin Place
SYDNEY NSW 2000
Dear Sir/Madam,
Mayne Pharma Group Limited – Request for Trading Halt
Mayne Pharma Group Limited (ASX: MYX) (Mayne Pharma) requests a trading halt in its securities with
immediate effect in accordance with Listing Rule 17.1 pending the release of an announcement in relation
to the decision of the Supreme Court of New South Wales, Court of Appeal related to Cosette’s appeal of
the judgement of the Supreme Court of New South Wales delivered on 15 October 2025. The Court of
Appeal’s decision is scheduled to be handed down after market open on 14 October 2026.
Mayne Pharma requests the trading halt remain in place until the earlier of the commencement of normal
trading on 16 October 2026, or when the above announcement is released to the market.
Mayne Pharma is not aware of any reason why the trading halt should not be granted and is not aware of
any other information that is necessary to inform the market about the trading halt.
This ASX announcement is authorised for release by the Chair of the Board of Mayne Pharma.
Yours faithfully,
Laura Loftus
Company Secretary
For further information contact:
Dr Tom Duthy
Investor Relations
+61 402 493 727
ir@maynepharma.com
Share your feedback
Discover